Daniel Brims
Stock Analyst at Lake Street
(0.05)
# 4,765
Out of 5,043 analysts
29
Total ratings
20.3%
Success rate
-33.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Brims
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RZLT Rezolute | Reiterated: Buy | $9 → $12 | $4.87 | +146.41% | 2 | Oct 6, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $89 | $28.51 | +212.17% | 2 | Sep 23, 2026 | |
| KYNB Kyntra Bio | Initiated Coverage: Buy | $41 | $6.11 | +571.03% | 1 | Sep 17, 2026 | |
| SPRB Spruce Biosciences | Initiated Coverage: Buy | $149 | $44.05 | +238.25% | 1 | Sep 17, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $23 | $10.60 | +116.98% | 5 | Sep 10, 2026 | |
| ALGS Aligos Therapeutics | Reiterated: Buy | $45 | $5.34 | +742.70% | 3 | Aug 7, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $9 | $0.799 | +1,026.41% | 1 | May 18, 2026 | |
| LITS Lite Strategy | Reiterated: Buy | $7 | $1.27 | n/a | 7 | Sep 2, 2015 | |
| IMNN Imunon | Reiterated: Buy | $7 | $1.08 | n/a | 6 | Aug 10, 2015 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Buy | n/a | $8.64 | n/a | 1 | Dec 30, 2014 |
Rezolute
Oct 6, 2026
Reiterated: Buy
Price Target: $9 → $12
Current: $4.87
Upside: +146.41%
Viking Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $89
Current: $28.51
Upside: +212.17%
Kyntra Bio
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $41
Current: $6.11
Upside: +571.03%
Spruce Biosciences
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $149
Current: $44.05
Upside: +238.25%
Kura Oncology
Sep 10, 2026
Reiterated: Buy
Price Target: $23
Current: $10.60
Upside: +116.98%
Aligos Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $5.34
Upside: +742.70%
Rani Therapeutics Holdings
May 18, 2026
Reiterated: Buy
Price Target: $9
Current: $0.799
Upside: +1,026.41%
Lite Strategy
Sep 2, 2015
Reiterated: Buy
Price Target: $7
Current: $1.27
Upside: n/a
Imunon
Aug 10, 2015
Reiterated: Buy
Price Target: $7
Current: $1.08
Upside: n/a
Bausch Health Companies Inc.
Dec 30, 2014
Reiterated: Buy
Price Target: n/a
Current: $8.64
Upside: n/a